Communication Breakdown, page-53

First 53 Last

Share
Profile

Follow
PulpCutter

1,429 Posts.

410

12/09/21

01:50

Post #: 55998086
Share

Originally posted by Andyrooo: ↑

We've got a MC of A$1.1b which includes A$350m in cash.

We made EBITDA of A$260m in FY2021. Similar is projected for FY2022.

Interest was Zero. Tax was Zero. Amortisation was Zero. That's a lot of bloody depreciation to come back to the NPAT of A$141.3m (Admin and expensed exploration expenditure assumed similar to FY2020 of A$31m).

We have a Resource with (theoretically) a Life of Mine for another 20 years. Will we have to spend A$100m in CapEx every year to mine it?

Otherwise, it appears we have free cash flow upwards of A$230m pa.

If everything remains the same, in 2 to 3 years time we'll have as much cash on hand as our MC, with a resource and plant in place for another 17 years of production.

I'm fairly new here, so perhaps I'm mistakenly looking at this too simply. Surely?

All other asset classes are at sky high valuations.

Expand

Strongly agree. I'd like to see Silver Lake institute a quarterly conference call, otherwise PATIENCE is about all that's required. I wouldn't argue with a share buyback, at these depressed prices, but have to assume management has a better view of what acquisition(s) might be available.

All of the above assumes spot gold does not go into a long-term decline. Anything is possible, but the fundamentals IMO favor continuing gold's long-term climb.

GLTA

SLR Price at posting: $1.30 Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

First 53 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Communication Breakdown, page-53

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Featured News